首頁 › 瀰漫性大B細胞淋巴瘤 › 明尼蘇達 › Rochester
Rochester, MN 的 瀰漫性大B細胞淋巴瘤 臨床試驗
10 項針對 瀰漫性大B細胞淋巴瘤 的研究正在 Rochester（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy
招募中2 期
- Mayo Clinic in Rochester, Rochester
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
招募中1/2 期
- Mayo Clinic Rochester, Rochester
Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
招募中2 期
- Mayo Clinic in Rochester, Rochester
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
招募中3 期
- Mayo Clinic - Rochester, Rochester
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
招募中1 期
- Mayo Clinic - Rochester, Rochester
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
招募中1 期
- Mayo Clinic - Rochester, Rochester
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
招募中1/2 期
- Mayo Clinic, Clinical Trials Referral Office, Rochester
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
招募中3 期
- Mayo Clinic Rochester, Rochester
DALY II USA/ MB-CART2019.1 for DLBCL
招募中2 期
- Mayo Clinic, Rochester
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
招募中2 期
- Mayo Clinic in Rochester, Rochester
其他城市的 瀰漫性大B細胞淋巴瘤 試驗
- New York City, NY21 項研究
- Baldwin Park, CA19 項研究
- Chicago, IL18 項研究
- Houston, TX17 項研究
- Los Angeles, CA17 項研究
- Boston, MA16 項研究
- Milwaukee, WI16 項研究
- Nashville, TN15 項研究
- Portland, OR15 項研究
- Philadelphia, PA15 項研究
- Durham, NC14 項研究
- Dallas, TX13 項研究
Rochester 的其他研究
- 乳癌42 項研究
- 非小細胞肺癌37 項研究
- 轉移性癌症31 項研究
- 癌症（所有類型）30 項研究
- 大腸直腸癌29 項研究
- 卵巢癌29 項研究
- 多發性骨髓瘤24 項研究
- 前列腺癌22 項研究
- 心臟衰竭22 項研究
- 胰臟癌22 項研究
- 肺癌20 項研究
- 子宮內膜癌20 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。